标题
Adoptive immunotherapy against ovarian cancer
作者
关键词
Adoptive-cell therapy, Ovarian Cancer, LAK, TILs, NK, CIK
出版物
Journal of Ovarian Research
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-05-17
DOI
10.1186/s13048-016-0236-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Immunotherapy for Ovarian Cancer
- (2015) Justin M. Drerup et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Cellular immunotherapy in ovarian cancer: Targeting the stem of recurrence
- (2015) Christina Wefers et al. GYNECOLOGIC ONCOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- Immunotherapy for ovarian cancer
- (2014) Emese Zsiros et al. CURRENT OPINION IN ONCOLOGY
- Adoptive immunotherapy against sarcomas
- (2014) Giulia Mesiano et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective
- (2014) Loretta Gammaitoni et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Past, present and future targets for immunotherapy in ovarian cancer
- (2014) Carlton L Schwab et al. Immunotherapy
- Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
- (2014) S. Watanabe et al. JOURNAL OF IMMUNOLOGY
- Maintenance Therapy With Autologous Cytokine-induced Killer Cells in Patients With Advanced Epithelial Ovarian Cancer After First-line Treatment
- (2014) Jun Liu et al. JOURNAL OF IMMUNOTHERAPY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
- (2013) L. B. John et al. CLINICAL CANCER RESEARCH
- Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
- (2013) Richard A. Morgan et al. JOURNAL OF IMMUNOTHERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell
- (2012) Deok Sung Bae et al. CELLULAR IMMUNOLOGY
- Cytokine-induced killer cells in the treatment of patients with solid carcinomas: a systematic review and pooled analysis
- (2012) Yue Ma et al. CYTOTHERAPY
- Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors
- (2012) Giulia Mesiano et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunogenetics of the NKG2D ligand gene family
- (2012) Masanori Kasahara et al. IMMUNOGENETICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors
- (2012) Dario Sangiolo Journal of Cancer
- Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
- (2011) A. Curti et al. BLOOD
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
- (2011) S. A. Rosenberg et al. CLINICAL CANCER RESEARCH
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Therapeutic cancer vaccines: are we there yet?
- (2010) Christopher A. Klebanoff et al. IMMUNOLOGICAL REVIEWS
- ULBP2 and RAET1E NKG2D ligands are independent predictors of poor prognosis in ovarian cancer patients
- (2010) Roger W. McGilvray et al. INTERNATIONAL JOURNAL OF CANCER
- Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: A Randomized Multicenter Phase II Trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group
- (2010) Jalid Sehouli et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-infiltrating NY-ESO-1–specific CD8+T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
- (2010) Junko Matsuzaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A systematic review of humoral immune responses against tumor antigens
- (2009) Miriam Reuschenbach et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- Surgical Management of Recurrent Ovarian Cancer
- (2009) Mario M. Leitao et al. SEMINARS IN ONCOLOGY
- Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis
- (2008) Kui Li et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Antigen-specific immunotherapy of cervical and ovarian cancer
- (2008) Chien-Fu Hung et al. IMMUNOLOGICAL REVIEWS
- Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer
- (2008) Gabriella Ferrandina et al. JOURNAL OF CLINICAL ONCOLOGY
- Sperm Protein 17 is a Suitable Target for Adoptive T-cell–based Immunotherapy in Human Ovarian Cancer
- (2008) Maurizio Chiriva-Internati et al. JOURNAL OF IMMUNOTHERAPY
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
- (2007) Ronald J Buckanovich et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search